UK healthcare leader Richard Meddings to chair Birmingham Health Partners
Richard Meddings CBE, the former chair of NHS England, has been appointed Chair of Birmingham Health Partners – signifying the importance, ambition and leadership of the second city’s NHS-university…
NIHR Clinical Research Facility celebrates year of growth and success
Birmingham’s NIHR/Wellcome Trust Clinical Research Facility (CRF) has celebrated yet another successful year, with thousands of patients and volunteers taking part in pioneering studies that are shap…
New vaccine trial for head and neck cancer patients
Patients in Birmingham who have advanced head and neck cancers may be eligible to take part in a new clinical trial of a potential cancer vaccine, supported by the NHS Cancer Vaccine Launch Pad (CVLP…
Birmingham academic appointed Clinical Lead of new NIHR network
The National Institute for Health and Care Research (NIHR) has awarded £6.5 million, funded jointly through a public-private partnership with the pharmaceutical industry, to establish a UK-wide Comme…
Adding dendritic cell vaccine to liver cancer therapy slows disease progression
Patients with intermediate-stage primary liver cancer who received a vaccine of dendritic cells (DC) alongside their cancer therapy saw a longer time without tumour progression in response to standar…
New trial to test novel diagnostic for bladder cancer recurrence
Nonacus, an early cancer testing company, has announced two West Midlands-based trials to assess a new way of monitoring for recurrence of bladder cancer, using a novel test developed in collaboratio…